Available Technologies
# of Displayed Technologies: 2 / 2
Applied Category Filter (Click To Remove): Other
Transducin β-like protein 1 X-Linked Selective Degraders as Anti-cancer Therapeutics
TS-062685 — Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers.
The Need
Current cancer treatments mainly rely on chemotherapy, radiation, surgery and bon…
- College: College of Pharmacy
- Inventors: Cheng, Xiaolin; Alinari, Lapo; Li, Pui-Kai "Tom"; Yang, Rui
- Licensing Officer: Taysavang, Panya
Development of STAT3 dimerization inhibitors for cancers
TS-037569 —
The constant activation of Signal Transducer and Activator of Transcription 3 (STAT3) is frequently detected in many cancer patients with advanced diseases. About 80% of all cancers overexpress STAT3, including solid tumors, lymphoma, and leukemia. Constant activation of STAT3 activities in nonmal…
- College: College of Pharmacy
- Inventors: Li, Pui-Kai "Tom"; Li, Chenglong; Lin, Jiayuh
- Licensing Officer: He, Panqing
